Article
An Activin A/BMP2 Chimera, AB204, Displays Bone-Healing Properties Superior to Those of BMP2
1 Apr 2014
Abstract excerpt
Recombinant bone morphogenetic protein 2 (rhBMP2) has been used clinically to treat bone fractures in human patients. However, the high doses of rhBMP2 required for a therapeutic response can cause undesirable side effects. Here, we demonstrate that a novel Activin A/BMP2 (AB2) chimera, AB204, promotes osteogenesis and bone healing much more potently and effectively than rhBMP2. Remarkably, 1 month of AB204...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
